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collagen gels, NRKproHB-EGF developed short tubule-like struc-Role of membrane-bound heparin-binding epidermal growth
tures in the absence of TPA treatment, but with simultaneousfactor-like growth factor (HB-EGF) in renal epithelial cell
TPA treatment, longer and more arborized structures devel-branching.
oped. MMP-1 mRNA and immunoreactive protein increased inBackground. The developing metanephros is characterized
the TPA-treated cells, suggesting that protein kinase C-mediatedby growth and differentiation of the ureteric bud and the sur-
rounding mesenchymal tissue. These processes can be influ- collagenase activity was important for the observed tubulogen-
enced by several growth factors, including epidermal growth esis. However, inhibition of EGF receptor tyrosine kinase with
factor (EGF) and transforming growth factor- (TGF-). We ex- AG 1478 significantly blunted the TPA-induced tubulogenesis
amined whether another member of the EGF family of growth by NRKproHB-EGF grown in collagen gels.
factors, heparin-binding epidermal growth factor (HB-EGF), Conclusions. These results indicate that membrane-bound
might act as a morphogen in renal epithelial tubulogenesis. HB-EGF can mediate both epithelial cell branching and cell
Methods. Expression of HB-EGF mRNA and immunoreac- motility. Localization of proHB-EGF to the site of cell-cell
tive protein were examined in fetal, neonatal and adult rat contact and development of tubule-like structures in collagen
kidneys. For in vitro studies of tubulogenesis, a rat renal epithe- gels suggests that proHB-EGF may be an important morpho-
lial cell line (NRK52E) stably transfected with proHB-EGF gen for renal epithelial cells.
(NRKproHB-EGF) was treated with TPA for 30 minutes, washed
with 2 mol/L NaCl to remove soluble HB-EGF trapped by cell
surface heparan sulfate proteoglycan and replated onto plastic
During metanephric kidney development, tubular struc-dishes in the absence of fetal calf serum. In further experiments,
NRKproHB-EGF were suspended in a type I collagen gel in serum- tures arise as a result of the initiation of tubulogenesis
free media. from epithelial and mesenchymal precursors and subse-
Results. Northern blot analysis indicated that HB-EGF was
quent branching morphogenesis [1]. These processes arestrongly expressed in embryonic rat kidney (embryonic days
regulated by mutually inductive epithelial-mesenchymal18-20) and was still increased in the neonatal kidney (day 10),
compared to the low basal levels in adult kidney. Immunohisto- interactions [2, 3]. In addition, interactions between epi-
chemical analysis confirmed that immunoreactive HB-EGF ex- thelial cells and extracellular matrix also have been im-
pression in the fetal rat kidney was localized predominantly plicated in renal tubular development [4].to the ureteric bud. When NRKproHB-EGF were plated onto plastic
Previous studies have suggested that locally producedsubstrata, they became progressively flattened and enlarged and
exhibited filopoidia. By 10 hours after plating, NRKproHB-EGF growth factors, including glial cell-derived neutrophic
began to migrate and subsequently developed cell-cell contact factor (GDNF), osteopontin-1 (OP-1), hepatocyte growth
and fully established tubular-like structures. Immunoelectron factor (HGF), insulin-like growth factors (IGF)-I and -2,microscopy revealed that the initial recovery of cellular proHB-
transforming growth factor- (TGF-) and epidermalEGF was localized predominantly to areas of cell-cell attach-
growth factor (EGF), may play a role in nephrogenesisment. No tubule-like structures were observed in similarly
treated NRK52E cells transfected with the vector alone. In and/or differentiation during renal development and in
renal regeneration following acute tubular injury [5–18].
Following the initial identification of EGF and the EGFKey words: juxtacrine activity, growth factor, kidney development, ure-
teric bud, morphogen, cell motility, tubulogenesis. receptor, other growth factors have subsequently been
identified that also signal through the EGF receptor, the
Received for publication September 10, 1999
so-called EGF family of growth factors [19–21]. One ofand in revised form January 11, 2002
Accepted for publication January 15, 2002 these growth factors, heparin-binding EGF-like growth
factor (HB-EGF) is a 22 kD glycoprotein that was origi- 2002 by the International Society of Nephrology
1968
Takemura et al: Membrane bound HB-EGF 1969
nally purified from conditioned media of U-937 cells, a [35]. The sequences of the forward primer: GGACCAT
GAAGCTGCTGCCGTCG and reverse primer: TAAmacrophage-like cell line [22]. In addition to macro-
phages, HB-EGF mRNA is expressed in other hemato- GGAACCGCCATCTCAGAAGT were based on the
published rat HB-EGF cDNA sequence [33]. The ampli-poietic cells, endothelial cells, vascular smooth muscle
cells and epithelial cells [23–26]. HB-EGF is a potent mi- fied PCR fragment was initially ligated into pPCR II
vector (Invitrogen, San Diego, CA) and sequenced, andtogen for smooth muscle cells, fibroblasts, keratinocytes,
intestinal epithelial cells and renal epithelial cells and is a the Hind III-Not I digested cDNA fragment of mem-
brane-anchored HB-EGF from this plasmid was subse-motility factor for smooth muscle cells and keratinocytes
[27–30]. Our previous studies found that HB-EGF ex- quently ligated into a eukaryotic expression vector (pRc/
CMV plasmid; Invitrogen).pression increased in rat kidney after acute ischemic
insult [30, 31], that HB-EGF also was expressed predom-
Transfectioninantly in the ureteric bud during rat metanephric devel-
opment [31], and in normal adult rat kidney, immunore- NRK 52E cells were purchased from ATCC (ATCC
No. CRL-1571; Rockville, MD, USA) and were stablyactive HB-EGF expression was predominantly confined
to tubules [30]. When NRK 52E cells, an immortal, non- transfected by lipofectin (Life Technologies, Gaithers-
burg, MD, USA) with proHB-EGF/pRc/CMV and selec-transformed rat renal epithelial cell line that expresses
EGF receptors, were transfected with proHB-EGF, these ted by continuous growth in G418 [400 g/mL Dulbecco’s
modified Eagle’s medium (DMEM); Geneticin; Lifecells were resistant to apoptotic injury by H2O2 or etopo-
side, and cell attachment was significantly increased [32]. Technologies, Grand Island, NY, USA). After seven pas-
sages, sixty individual clones were isolated and screenedMembers of the EGF family of growth factors are
synthesized as membrane-anchored precursors [33]. The for proHB-EGF expression by dot northern blot analysis
using 32P-labeled EcoR I digested membrane-anchoredprecursor for HB-EGF (proHB-EGF) exists as a 206
amino acid transmembrane protein and undergoes pro- HB-EGF cDNA fragment. Three clones (E15, E24 and
E56) expressing high levels of message were identifiedcessing to an 86 amino acid secreted protein (mature
HB-EGF) [22, 29]. Both the membrane bound TGF- and were utilized in these studies. All responses to growth
conditions, agonists and antagonists were confirmed inprecursor and preproEGF have been shown to activate
EGF receptors in adjacent cells and to stimulate the cells all three clones and were qualitatively indistinguishable.
Unless otherwise indicated, the representative figuresto proliferate in a juxtacrine manner [19]. Recent studies
by others and us also have indicated that proHB-EGF are results obtained from clone E15. As a control, NRK
52E cells also were transfected with pRc/CMV plasmidmay be capable of juxtacrine stimulation [32–34]. Juxta-
crine stimulation has been suggested to be a mechanism alone and grown and maintained in G418. Details of
these clones have been previously reported [32].by which adjacent cells can directly exchange biological
signals necessary for cell survival and which can contrib-
Cell cultureute to maintenance of cell-cell contact [32]. Therefore,
the present studies were designed to determine whether Non-transfected NRK 52E (wt), vector transfected
(NRKvector) and membrane-anchored HB-EGF transfectedmembrane-anchored HB-EGF play a role in renal tubu-
lar morphogenesis. cells (NRKproHB-EGF) were routinely grown in DMEM
(Sigma Chemical Co., St. Louis, MO, USA), containing
10% fetal calf serum (FCS; Hyclone, Logan, UT, USA)
METHODS
supplemented with 100 U/mL ampicillin and 100 g/mL
Animal studies streptomycin. Transfected cells were routinely grown in
Geneticin (G418 sulfate, 400 g/mL; Life Technologies).Timed pregnancies were performed in Sprague-Daw-
ley rats. Samples from adult male rats (weighing 150 to To activate protein kinase C, 12-O-tetradecanoylphorbol
13-acetate (TPA; 10-7 mol/L) was added to quiescent200 g) were also obtained.
cells for 30 minutes prior to trypsinization and replating
cDNA and vectors on the indicated substratum, using a protocol previously
reported to promote angiogenesis [36].Male Sprague-Dawley rats were given gentamicin 200
mg/kg every 12 hours for two days in order to increase renal
Production of collagen gelsHB-EGF mRNA expression [31]. Following sacrifice, kid-
neys were removed for total RNA extraction by ISOGEN Five volumes of type I collagen solution (Cellmatrix
IA; Nitta Zelatin Inc., Osaka, Japan) were mixed withregent (Nippon Gene, Toyama, Japan). A rat membrane-
anchored HB-EGF cDNA was developed by reverse four volumes of 2.5 concentrated DMEM and 1 volume
of 0.05 NaOH with 2.2% NaHCO3 and 200 mmol/Ltranscriptase-polymerase chain reaction (RT-PCR) am-
plification from an extracted RNA of a 692 bp fragment HEPES and heated to 37C. The wells were first coated
with 5 mL collagen. Cells (105 cells/6 well plate) wereof the rat membrane-anchored HB-EGF coding region
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then mixed in a volume of 5 mL of collagen and overlaid. munofluorescent staining, cells were incubated with the
primary antibody after fixation with 1% glutaraldehyde/Following gelation, 3 mL of DMEM was overlaid.
PBS, washed in phosphate buffered saline (PBS), and
RNA isolation and Northern blot analysis then reacted with the appropriate secondary antibody
labeled with fluorescein-isothianate (FITC). Immuno-Total RNA from cultured cells was extracted and sub-
jected to Northern blot analysis according to previously peroxidase staining was carried out as reported pre-
viously [36, 37]. Briefly, tissues fixed with paraformalde-described methods [30]. Aliquots of total RNA, each con-
taining 10 to 15 g, were subjected to electrophoresis, hyde-lysine periodate (PLP) were cut into thin sections,
and treated with periodate and sodium borohydroxide totransferred to S & S Nytran nylon membranes (Schlei-
cher & Schuell, Keene, NH, USA), and fixed to the mem- inhibit endogenous peroxidase. Each section was reacted
with anti-HB-EGF antibody, then with secondary anti-brane by exposing to UV (CL-1000, Ultraviolet Cross-
linker; Funakoshi Co., Tokyo, Japan). The membranes body labeled with horseradish peroxidase (HRPO; Cap-
pel). As controls, kidney sections or cultured NRK 52Ewere prehybridized in a solution of 30% formamide, 5
standard sodium citrate (SSC), 5  Denhardt’s (Wako cells were incubated with nonimmune mouse sera or with
unrelated mouse IgG monoclonal antibody, followed byPharmaceutical Co., Osaka, Japan), and 100 g/mL soni-
cated salmon sperm DNA (Invitrogen) at 42C. Follow- incubation with FITC or HRPO-labeled goat anti-mouse
IgG, or with secondary antibody alone. These controlsing prehybridization, blots were hybridized with 0.5 to
1.07 cpm/mL of 32P-labeled cDNA overnight at 42C. The were entirely negative.
For immunoelectron microscopy, cells were rinsedcDNA probes utilized included a 686 bp EcoR I frag-
ment of rat membrane-anchored HB-EGF, 1.3 kb PstI- with ice-cold PBS and fixed with PLP fixative solution
and treated progressively with 10 to 20% sucrose in PBS.BamH I fragment of rat type I collagen, 2.23 kb EcoR
I-BamH I fragment of rat type III collagen and a 760 bp They were then incubated with periodate and sodium
borohydrate to inhibit endogenous peroxidase and re-EcoR I fragment of rat EGF receptor, which were la-
beled to 108 cpm/g by the random priming procedure acted with HB-EGF antibody, followed by the peroxi-
using a commercially available kit (Amersham, Arling- dase-labeled F(Ab)2 fragment of rabbit anti-goat IgG.
ton Heights, IL, USA). After washing with 2  SSC for The cells were fixed with 1% glutaraldehyde in PBS,
15 minutes at room temperature twice, and at 65C with incubated with diaminobenzidine/hydrogen peroxide and
1  SSC/0.1% sodium dodecyl sulfate (SDS) for 15 min- post-fixed with osmic acid. They were then treated with
utes, and finally with 0.2% SSC/0.1% SDS for an addi- graded ethanol solutions (50, 70, 80, 90, 100%) for five
tional 15 minutes, the membranes were exposed to Kodak minutes each and embedded in Epon 812. Ultrathin sec-
X-Omat AR film at 70C with an intensifying screen. tions were observed under an electron microscope (H-7100;
The blots were stripped and reprobed with a human glyc- Hitachi, Tokyo, Japan) without lead citrate or aqueous
eraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA uranyl acetate staining.
using the conditions of labeling, hybridization, and wash-
ing as described above. The levels of mRNA were quan-
RESULTStitated by densitometry and normalized to GAPDH ex-
Localization of HB-EGF protein in the embryonic ratpression.
metanephros. Heparin binding-EGF mRNA expression
Antibodies and chemicals in the embryonic developing rat kidneys and the adult
rat kidneys was determined by Northern blot analysis.Goat anti-rat HB-EGF antibody was kindly provided
As shown in Figure 1A, significant HB-EGF mRNAby Judith Abraham of Scios, Inc. (Mountain View, CA,
expression was observed in rat metanephric kidney atUSA), rabbit anti-EGF receptor antibody was from
embronic (e) days e18 and e20. By postnatal day 10, HB-Calbiochem (La Jolla, CA, USA), HB-EGF and rabbit
EGF mRNA expression was decreased compared to fetalanti-human HB-EGF antibody was from Santa Cruz
expression but was still greater than that seen in kidneysBiochemicals (Santa Cruz, CA, USA). Anti-F-actin was
for adult rats. Immunological localization using an anti-purchased from Molecular Probe Inc (Oregon, Eugene,
HB-EGF polyclonal antibody confirmed our previousUSA), and anti--tubulin was from Calbiochem. Rho-
observation [31] that the HB-EGF protein in the meta-damine-labeled sheep anti-rabbit and FITC-labeled don-
nephric kidney (e18) was initially expressed in the ure-key anti-goat antibodies were from Cappel Laboratories
teric buds (Fig 1B). In the present studies, we determined(Durham, NC, USA). 12-O-tetradecanoylphorbol 13-ace-
that HB-EGF immunoreactivity persisted in the kidneytate was purchased from Sigma.
during late embryogenesis in structures derived from
Immunohistochemistry the ureteric buds. In later fetal and postnatal kidneys
(through postnatal day 28), HB-EGF immunoreactivityDirect or indirect immunofluorescent staining was per-
formed as described previously [37, 38]. For indirect im- was also detected in the smooth muscles of the interlobu-
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These cells were then subcultured on plastic dishes at a
density 1105 cells/7 mL of medium in the absence of
fetal calf serum (FCS). Wild type (Wt ) and vector-trans-
fected cells (NRKvector) underwent identical treatment.
Initially after plating, TPA-pretreated NRKproHB-EGF re-
mained rounded (Fig 2A). At this time, both F-actin
filaments (Fig. 2B) and -tubulin (Fig. 2C) were weakly
distributed in the perinuclear region and sequestered
around the canalicular domain. After six hours of cul-
ture, there was increased expression of F-actin and
-tubulin, with more widespread distribution throughout
the cytoplasm. During the period from 6 to 12 hours,
there was progressive cell attachment and elongation,
with development of filopodial extensions.
By 10 hours, there was evidence of initial contact by
TPA-pretreated NRKproHB-EGF (Fig. 3A). By 12 to 16 hours,
single epithelial cell strands were observed (Fig. 3 B, C).
By 16 to 20 hours, the initial epithelial branches had
extended and begun to join to adjacent branching cell
aggregates (Fig. 3 D, E), which persisted over the subse-
quent 16 hours (Fig. 3 F-H). When NRKproHB-EGF were
plated in FCS deficient media without pretreatment with
TPA, they did not form tubule-like structures (Fig. 3I). In
NRKproHB-EGF, but not in NRKvector, EGF receptor mRNA
expression increased progressively within the first 12 hours
after plating (Fig. 4 A, B). By 12 hours after plating, im-
munofluorescent EGF receptors were concentrated at
Fig. 1. (A) Northern blot analysis for HB-EGF mRNA extracted from the sites of cell attachment (Fig 4C). A similar pattern of
embryonic (e18, e20), newborn (p10) and 12-week-old (adult) rat kid- immunofluorescent HB-EGF localization was noted (Fig
neys. Expression of GAPDH mRNA is shown for comparison. (B) Im-
4D). Immunoelectron microscopy with HRPO-labeledmunohistological staining for HB-EGF in the rat embryonic kidney (e18).
HB-EGF protein was localized predominantly in the ureteric bud. anti-rat HB-EGF further indicated that the initial recov-
ery of HB-EGF in NRKproHB-EGF was localized mainly to
areas of cell-cell attachment (Fig. 4E).
lar arteries and afferent arterioles (data not shown). In Tubule formation in NRK 52E cells grown in
contrast, in normal adult rat kidneys, minimal HB-EGF collagen gels
immunoreactivity was detectable. To examine growth in collagen gels, cells were again
pretreated with TPA for 30 minutes prior to replatingEpithelial cell branching mediated by
in the gel. When NRKproHB-EGF were suspended in a type Imembrane-anchored HB-EGF (proHB-EGF)
collagen gel in serum-free media, they developed epithe-
To investigate the potential role of proHB-EGF in lial branching cords by day 1, and by day 2, exhibited cyto-
tubule formation, rat proHB-EGF was constitutively ex- plasmic processes forming small luminal spaces (Fig. 5).
pressed in NRK-52E cells, an immortalized epithelial Beginning at day 3, the cells extended into the sur-
cell line derived from rat kidney. Since cleavage of rounding collagen matrix, became progressively elon-
membrane-associated pro-HB-EGF to its soluble pep- gated and began to branch, with arborized structures
tide is regulated by protein kinase C-activated cleavage, present by day 6 (Fig. 5, A–F). Electron microscopy
with maximal loss of cell-surface proHB-EGF occurring indicated polarized tubules, with a smooth basal surface
within 30 to 60 minutes after PKC activation and subse- in contact with the collagen matrix and a microvillus-
quent restoration of membrane-associated proHB-EGF rich apical surface facing the lumen (Fig 5G).
within the next 6 to 12 hours [39, 40]. NRKproHB-EGF were To determine possible mechanisms by which proHB-
preincubated with 0.1 mol/L 12-O-tetradecanoylphorbol EGF expression and protein kinase C (PKC) activation
13-acetate (TPA) for 30 minutes to cleave the soluble interact to promote tubulogenesis in NRK-52E cells, we
(mature) HB-EGF, followed by washing with DMEM examined expression of the metalloproteinase, matrix
containing 2 mol/L NaCl to remove soluble HB-EGF metalloproteinase-1 (MMP-1). Under baseline condi-
tions, NRKproHB-EGF expressed minimal MMP-1 mRNAtrapped by cell surface heparan sulfate proteoglycan [39].
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Fig. 2. Morphologic appearance of TPA-treated NRKproHB-EGF plated
in fetal calf serum (FCS)-free medium. (A) At 3 hours after plating,
cells remained rounded (A), but after 6 hours, cells had flattened and
attached to the plastic substratum (B); after 9 hours cells had elongated
with a leading cytoplasmic filopoidal extension, (C) and after 12 hours,
cells had an elongated, spindle-like morphology (D). (B) Alterations
in F-actin distribution in TPA-treated NRKproHB-EGF plated in FCS free
medium. At 3 hours after plating, cytoskeletal F-actin was weakly visible
in the cytoplasm, without extension from the cell center (A). By 6
hours, large bundles of cortical F-actin were observed (arrows; B).
There was a more widespread distribution at 9 hours (C) and by 12 hours
was widely distributed throughout the cytoplasm (D). (C ) Alterations in
-tubulin distribution in TPA-treated NRKproHB-EGF plated in FCS-free
medium. Low levels of immunoreactive -tubulin were observed at 3
hours after plating (A); by 6 hours, -tubulin was concentrated in the
perinuclear region (B). By 9 hours, it was present in the filopoidal
cytoplasmic domains (C), and at 12 hours was extended widely through-
out the cytoplasm (D).
or immunoreactive protein (Fig. 6). After pretreatment form small tubule-like structures compared to the TPA-
treated tubules (Fig.7B). However, addition of the rela-of these cells with TPA, there was increased expression
of MMP-1 mRNA by 24 hours, and a corresponding tively selective EGF receptor tyrosine kinase inhibitor
AG 1478 (0.3 mol/L) blunted the tubule formation inincrease in immunoreactive MMP-1, with an apparently
maximal expression by 48 hours. Addition of the metallo- TPA-treated NRKproHB-EGF cells (Fig. 7C). Furthermore,
addition of an anti-rat HGF antibody (T. Nakamura,proteinase inhibitor 1.10-phenanthroline greatly reduced
tubulogenesis of the TPA-treated NRKproHB-EGF cells Osaka University, Osaka, Japan) or an anti-GDNF anti-
body (R & D Systems, Minneapolis, MN, USA) did notgrown in collagen gels.
To further investigate the interactions of proHB-EGF affect tubule formation in TPA-treated NRKproHB-EGF cells.
Quantitation of the percentage of colonies with branch-and protein kinase C in promoting tubulogenesis in colla-
gen gels, we compared tubule formation in clone E15 of ing processes is indicated in Figure 8. As also indicated
in Figure 8, neither TPA-treated wt nor NRK vectorNRKproHB-EGF cells grown in collagen gels in the absence
or presence of TPA treatment (Fig. 7). As indicated in formed branching processes when plated under the iden-
tical conditions. In addition, no tubulogenesis was ob-Figure 7A, without PKC activation, the transfected cells
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Fig. 3. Branching morphogenesis in NRKproHB-EGF. After plating on plas-
tic substratum in the absence of FCS, TPA-treated NRKproHB-EGF under-
went branching morphogenesis, (A, 10 h; B, 12 h; C, 14 h; D, 16 h; E,
20 h). Over the ensuing 16 hours, further tubule-like development was
noted (F, 24 h; G, 30 h; H, 36 h). In contrast, without TPA pretreatment,
NRKproHB-EGF plated on plastic in the absence of FCS presented as charac-
teristic epithelial cell colonies (I, 24 h).
served if Wt or NRKvector were plated in collagen gels in nephroi or in vitro tubulogenesis assays [11–13], although
genetically engineered mice deficient in either HGF orthe presence of soluble HB-EGF (107 mol/L).
insulin-like growth factors have not exhibited phenotypic
abnormalities in renal development [43–45], suggesting
DISCUSSION redundancy in these regulatory pathways.
Cell proliferation, motility, differentiation and extra- Previous studies also have indicated a role for EGF
cellular matrix production are all critical events during or EGF family members in renal development [14–18,
embryonic tissue development [41]. Metanephric kidney 46–53]. Both the number and extent of tyrosine phos-
development is characterized by epithelial cell growth phorylation of EGF receptors increase in the developing
and differentiation from the ureteric buds and induction kidney during late fetal development, co-incident with
of the surrounding mesenchymal cells [3]. Although mo- the timing of tubulogenesis and glomerulogenesis [14, 15].
lecular mechanisms underlying these processes have not Addition of EGF to uninduced metanephrogenic mesen-
been completely clarified, inductive signals regulating chyme in culture induces differentiation into stroma but
renal tubulogenesis may be mediated by both cell-cell not epithelial cells, arguing against an essential role for
and cell-extracellular matrix (ECM) interactions [42]. EGF family members in induction of the metanephric
Studies in genetically engineered mice have demon- blastema [46]. However, EGF or TGF- has been shown
strated an essential role for GDNF/c-ret interactions in to be important for branching tubulogenesis of renal epi-
induction of nephrogenesis [5–8], and other studies have thelial cell in matrigel, and in complete metanephric
also indicated an essential role for bone morphogenic organ culture, in which induction of the mesenchyme by
protein-7 (BMP-7)/OP-1 [9, 10]. Other growth factors ureteric bud occurs, administration of EGF increases
such as HGF and IGF-1 have been implicated in meta- growth and differentiation of collecting ducts but de-
creases differentiation of glomeruli and proximal tubulesnephric development in studies utilizing cultured meta-
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Fig. 4. (A) Northern blot analysis of EGF receptor expression after
replating TPA-treated NRKproHB-EGF. (B) Northern blot analysis of EGF
receptor expression after replating TPA-treated NRKvector. Expression
of GAPDH mRNA is shown for comparison. (C ) Immunolocalization
of EGF receptor at 16 h after plating. (D) Immunolocalization of HB-
EGF in the same cells at 16 h after plating. (E ) Immunoelectron micros-
copy of immunoreactive HB-EGF (24 h). Note the concentration of
immunoreactive HB-EGF at the membrane surface adjacent to neigh-
boring cell (arrows).
[16–18, 46, 47]. Furthermore, administration of tyrosine that in fetal kidney, EGF administration decreases apo-
ptotic cell death in the nephrogenic zone of the devel-kinase inhibitors, EGF receptor blocking antibodies or
anti-TGF- antibodies to metanephric cultures all block oping kidney cortex and in the developing medullary
papilla [54, 55].differentiation of the structures arising from ureteric bud
[48, 49]. Homozygous mice engineered with a targeted It has not yet been determined which EGF-like growth
factors may be mediating the EGF receptor-mediateddisruption of the EGF receptor also have evidence of ab-
normalities in differentiation of structures derived from responses in renal development. Salido et al reported
that EGF was expressed substantially only at the end ofureteric bud [50]. Of interest, two groups have reported
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Fig. 5. Growth of TPA-treated NRKproHB-EGF in collagen gels at (A)
day 0, (B) day 1, (C ) day 2, (D) day 3, (E ) day 4, (F, G ) day 6. In
panels D–F, arrows indicate developing lumen. In panel G, Lu is the
lumen and JC the junctional complex; small arrows show the microvilli.
kidney by PCR but was expressed at low levels (60 cycles
were required for detection) [49].
In addition to EGF and TGF-, other members of
the EGF family of growth factors include amphiregulin,
vaccinia growth factor, betacellulin, and HB-EGF [20–
22, 32]. A common structural feature of these peptides is
single or multiple EGF-like repeats in the extracellular
domain, consisting of six cysteine residues that form three
intramolecular disulfide bonds [32]. As an initial investi-
gation of whether other EGF family members might be
involved in renal development, we evaluated the role of
HB-EGF in epithelial tubular morphogenesis. Immuno-
histochemical staining and northern blot analysis revealed
that both HB-EGF protein and mRNA were strongly ex-
pressed in the embryonic kidney at day 14 to 18, with
persistence of high expression in the neonatal period.Fig. 6. Expression of MMP-1 in TPA-treated NRKproHB-EGF in collagen
gels. Either mRNA or protein was extracted at the indicated time and Interestingly, HB-EGF protein expression in developing
probed for expression of MMP-1 mRNA or immunoreactive protein. kidney was localized initially to the ureteric buds. Since
inhibition of EGF receptor function appears to interfere
with differentiation of structures arising from the ure-
gestation or postnatally [51]. TGF- mRNA was de- teric bud [50], our findings suggest that HB-EGF may be
tected by in situ hybridization in day 8 to 10 mouse an important or necessary ligand for EGF receptor acti-
embryonic mesonephric kidneys but was absent at later vation during renal development.
times in the developing metanephric kidney, nor was To delineate further a potential role of HB-EGF in epi-
there any detection of TGF- mRNA by Northern blot thelial cell branching, we utilized NRK 52E cells that were
analysis in rat embryos after embryonic day 10 [52, 53]. stably transfected with proHB-EGF. We have previously
found that NRKproHB-EGF exhibited a faster growth rate thanTGF- mRNA was detected in cultured metanephric
Takemura et al: Membrane bound HB-EGF1976
Fig. 7. Effect of an EGF receptor tyrosine kinase inhibitor on growth
TPA-treated NRKproHB-EGF in collagen gels. NRKproHB-EGF were plated in
collagen gels without TPA treatment (A), which gave shorter, less well
developed tubule-like structure than in cells plated in the presence of
TPA (B). When TPA treated cells were simultaneously exposed to
AG1478 (0.3 mol/L), tubulogenesis was blunted (C ).
NRKvector when grown in 1% FCS, and when NRKproHB-EGF
were plated in the absence of FCS, NRKproHB-EGF had
greater attachment, spreading and cell-cell contact than
NRKvector [32]. Our previous studies also demonstrated
that expression of proHB-EGF in NRK-52E cells pro-
tected against acute cell injury-induced apoptosis in the
absence of serum or other exogenous growth promoting
agents [32].
Goishi et al previously demonstrated that the phorbol
ester, TPA, can cleave membrane-associated HB-EGF
to produce soluble HB-EGF, with subsequent recovery
of membrane anchored HB-EGF after 12 to 24 hours [39].
In the present studies, when NRKproHB-EGF were treated
with TPA, washed with 2 mol/L NaCl to remove adher-
ent soluble HB-EGF and then replated in FCS-deficient
medium, they formed branching tubule-like structures.
PKC activation initiates a variety of cell signaling pro-
cesses in addition to proHB-EGF cleavage. It should be
noted, however, that the addition of TPA did not induce
Fig. 8. Branching of TPA-treated transfected NRK cells grown in type tubule formation in vector transfected cells, indicating
I collagen gels. Cells were pretreated as described in the text. Each time that PKC activation alone was not a sufficient stimuluspoint represents the assessment of 100 colonies. There was essentially no
for tubulogenesis. Our previous studies with NRK-52Ebranching noted in NRKvector cells. Symbols are: () NRKproHB-EGF 
TPA; () NRKproHB-EGF TPA; () NRKproHB-EGFTPA and pretreated cells, in which neither expression of proHB-EGF or addi-
with AG 1478; () NRKvector  TPA; () NRKvector  TPA. P  0.05, tion of soluble HB-EGF alone induced tubule formationNRKproHB-EGF  TPA vs. NRKproHB-EGF  TPA; P 0.001, NRKproHB-EGF 
TPA vs. NRKproHB-EGF  TPA and pretreated with AG 1478. [32], indicates the importance of simultaneous activation
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of PKC-mediated pathways and EGF receptor-mediated and -tubulin. These findings suggest that HB-EGF may
be a mediator of cell motility in NRK 52E cells.pathways
It is noteworthy that the timing of reappearance of Finally, it is important to remember the inherent limi-
tations of in vitro systems in investigating tubulogenesis.membrane associated HB-EGF coincided with the initia-
tion of branching, and that membrane associated HB- As an example, HGF induces tubulogenesis in MDCK
cells, while EGF ligands are ineffective [17]. In contrast,EGF was found predominantly at the sites of cell-cell at-
tachment. This finding suggests that juxtacrine or tightly EGF ligands effectively promote tubulogenesis in IMCD-3
cells [18], as well as in NRK52E cells. Sakurai et al havecoupled autocrine interactions of HB-EGF with adjacent
EGF receptors may be crucial for the development of evaluated the tubulogenic activity of cultured medium
derived from cultured metanephric mesenchymal cellsthe observed branching. Therefore, a combination of
PKC activation and expression of membrane associated and have determined that only approximately 50% of
tubulogenic activity was inhibited by a combination ofHB-EGF may be necessary to initiate tubule formation
in NRK52E cells. AG1478 and anti-HGF antibody treatment [58] sug-
gesting that EGF receptor ligands may be only one ofAlthough these initial studies did not elucidate the
cellular mechanisms underlying this interaction, it is note- a number of participant factors that induce and/or modu-
late tubulogenesis in the developing kidney.worthy that TPA treatment induced expression of the
metalloproteinase, MMP-1, in the proHB-EGF trans- In summary, these results indicate that membrane-
anchored HB-EGF initiates and facilitates renal epithe-fected cells. Previous studies have suggested that phorbol
ester-induced metalloproteinase activity is also impor- lial cell branching, possibly by promoting cell-cell and
cell-matrix interactions and regulating cell movement.tant for in vitro angiogenesis [36]. Since proHB-EGF is
a survival factor for NRK-52E cells [32], and EGF ap- We speculate that HB-EGF may play a role in distal
tubule growth and differentiation during metanephricpears to inhibit apoptosis during nephrogenesis [54, 55],
it is also possible that the predominant effect of proHB- development. Furthermore, in the adult kidney, in re-
sponse to tubular injury, soluble HB-EGF may be cleavedEGF was to prevent apoptosis and thereby allow other
PKC-dependent tubulogenic processes to proceed. How- from its membrane-anchored precursor by proteases and
participate in recovery of the injured cells and cell prolif-ever, in preliminary studies, we determined that in cells
cultured in 1% FCS, in which no detectable apoptosis eration. As cells recover and differentiate, proHB-EGF
will be restored to the cell surface and may act as a jux-was observed, tubulogenesis again occurred in response
to TPA treatment only in NRKproHB-EGF and not in NRKvector. tacrine or tightly coupled autocrine factor to mediate re-
organization of cell-cell and cell-ECM contact. FurtherIt has been suggested that membrane-anchored growth
factor precursors are biologically active, and may contact studies will be needed to define the intracellular signaling
pathways activated in response to such interactions.and activate cognate receptors on adjacent cells, estab-
lishing a mode of stimulation known as juxtacrine stimu-
lation [32]. In recent studies, we detected increased ACKNOWLEDGMENTS
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